0.05]與對(duì)照組比較無統(tǒng)計(jì)學(xué)意義。結(jié)論 蘇黃止咳膠囊治療感冒后咳嗽的臨床療效好,不良反應(yīng)少。;Objective To evaluate the efficacy and safety of Suhuang Zhike Capsule (SZC) in the treatment of post-cold cough. Methods Computer retrieval of Wanfang, CNKI, VIP, and CBM on SZC in the treatment of post-cold cough clinical randomized controlled study (RCTs). Reaching time from January 2007 to June 2015. The control study was carried out by RevMan5.0 software. Results Totally 42 papers were preliminary retrieved in strict accordance with the inclusion and exclusion criteria, nine papers were finally selected. Meta-analysis suggested that the clinical efficacies of experimental groups (SZC groups) in the treatment of post-cold cough were as follows:[healing rate OR=3.15, 95%CI 2.33-4.26, P<0.00001; cure rate OR=12.30, 95%CI 1.64-3.25, P<0.00001; effective rate OR=4.65, 95%CI 3.10-6.98, P<0.00001]. Compared with the control group, there was statistical significance. Incidence of adverse reactions[OR=1.09, 95%CI:0.29-4.14, P>0.05], compared with the control group, there was no statistical significance. Conclusion The clinical efficacy of SZC in the treatment of post-cold cough clinical effect is good, and the adverse reaction is little."/>